NanoString Prices IPO at $10 per Share | GenomeWeb

NEW YORK (GenomeWeb News) – NanoString Technologies late on Tuesday priced its planned initial public offering at $10 per share.

The company expects to offer 5.4 million shares of its common stock in the offering. In a prospectus filed today, NanoString said that it anticipates net proceeds from the offering of about $50.2 million.

Additionally, it has granted the underwriters a 30-day option to purchase up to 810,000 shares to cover any over-allotments.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: map of UV-induced damage in yeast genome, comparative epigenomics uncovers plant lacking key DNA methyltransferase enzyme, and more.

Researchers kick off their second Queer in STEM survey to examine what can make STEM careers welcoming, Wired reports.

A startup company is offering a test to analyze soil samples from farms for pathogens.

Prosecutors seek to introduce evidence from low-template DNA analysis in a murder case in upstate New York, the New York Times reports.